![Jae-Joon Kim](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jae-Joon Kim
Directeur/Membre du Conseil chez
YOUCEL, Inc.
Profil
Jae-Joon Kim currently works at Mirae Asset Venture Investment Co., Ltd., as Senior Managing Director, ImmunoMet Therapeutics, Inc., as Director from 2016, and YOUCEL, Inc., as Non-Executive Director.
Postes actifs de Jae-Joon Kim
| Sociétés | Poste | Début |
|---|---|---|
Mirae Asset Venture Investment Co., Ltd. /Venture Capital/
 Mirae Asset Venture Investment Co., Ltd. /Venture Capital/ Investment ManagersFinance Mirae Asset Venture invest in companies across the globe, particularly in South Korea. The firm targets companies operating in the nformation and communication, internet, biotechnology and environment sectors. It provides financing for early stage capital requirements and buyouts.. | Private Equity Investor | 01/01/2018 |
ImmunoMet Therapeutics, Inc.
 ImmunoMet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops drugs for the treatment of cancer | Directeur/Membre du Conseil | 01/03/2016 |
YOUCEL, Inc.
 YOUCEL, Inc. BiotechnologyHealth Technology Develops bio-cellulose technology | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
18
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Mirae Asset Venture Investment Co., Ltd. /Venture Capital/
Mirae Asset Venture Investment Co., Ltd. /Venture Capital/ Investment ManagersFinance Mirae Asset Venture invest in companies across the globe, particularly in South Korea. The firm targets companies operating in the nformation and communication, internet, biotechnology and environment sectors. It provides financing for early stage capital requirements and buyouts.. | Finance |
ImmunoMet Therapeutics, Inc.
ImmunoMet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops drugs for the treatment of cancer | Health Technology |
YOUCEL, Inc.
YOUCEL, Inc. BiotechnologyHealth Technology Develops bio-cellulose technology | Health Technology |
